Timothy L Cannon, Joel Ford, Danubia Hester, Donald L Trump
{"title":"The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer.","authors":"Timothy L Cannon, Joel Ford, Danubia Hester, Donald L Trump","doi":"10.1089/crpc.2016.0003","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Pancreatic adenocarcinoma is associated with a very poor prognosis, with a 5 year survival of ∼7.2%. Vitamin D has long been evaluated for benefit as a protective agent and treatment for malignancies. Although cancer incidence and outcomes have been tied to vitamin D levels, there is no clear evidence that supplementation of vitamin D improves outcome in pancreatic cancer to date. <b>Case Presentation:</b> We present a patient who errantly took supratherapeutic doses of vitamin D 50,000 U daily, achieving a serum 25(OH)D level of more than 150 mg/mL, with no appreciable side effects. <b>Conclusion:</b> Her disease was stable for 8 months off of conventional treatment, although it is unclear whether this was related to vitamin D supplementation.</p>","PeriodicalId":92486,"journal":{"name":"Case reports in pancreatic cancer","volume":"2 1","pages":"32-35"},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/crpc.2016.0003","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case reports in pancreatic cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/crpc.2016.0003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Background: Pancreatic adenocarcinoma is associated with a very poor prognosis, with a 5 year survival of ∼7.2%. Vitamin D has long been evaluated for benefit as a protective agent and treatment for malignancies. Although cancer incidence and outcomes have been tied to vitamin D levels, there is no clear evidence that supplementation of vitamin D improves outcome in pancreatic cancer to date. Case Presentation: We present a patient who errantly took supratherapeutic doses of vitamin D 50,000 U daily, achieving a serum 25(OH)D level of more than 150 mg/mL, with no appreciable side effects. Conclusion: Her disease was stable for 8 months off of conventional treatment, although it is unclear whether this was related to vitamin D supplementation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
